BioNTech co-founders Uğur Şahin and Özlem Türeci will discuss using mRNA technology in vaccines to treat cancer and COVID-19.
LMB News
Andrew McLachlan (1935 – 2022)
Andrew McLachlan, former Group Leader in the LMB’s Structural Studies Division and a pioneer of structural bioinformatics, died on Thursday 7th July 2022, aged 87.
Madeline Lancaster and Menna Clatworthy elected to EMBO membership
Madeline Lancaster, Group Leader in the LMB’s Cell Biology Division, and Menna Clatworthy, Group Leader in the University of Cambridge Molecular Immunity Unit (housed at the LMB) are new members of EMBO.
Kelly Nguyen has won the 2022 Eppendorf Award for Young European Investigators
Structural Studies Group Leader Kelly Nguyen has been honoured by the 2022 Eppendorf Award for Young European Investigators for her innovative research on the spliceosome and telomeres.
Lister Institute Prize Lectures delivered at LMB
Tanmay Bharat, LMB, and Ravindra Gupta, Cambridge Institute for Therapeutic Immunology and Infectious Diseases, delivered lectures after receiving Lister Institute Research Prizes last year.
LMB students recognised by Cambridge Society for the Application of Research
Congratulations to Katerina Naydenova and Vaithish Velazhahan, PhD students in the LMB’s Structural Studies Division who have received PhD Student Awards from CSAR